Cargando…
SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation
We have previously shown that overexpression of SKI, an endogenous TGF-β(1) repressor, deactivates the pro-fibrotic myofibroblast phenotype in the heart. We now show that SKI also functions independently of SMAD/TGF-β signaling, by activating the Hippo tumor-suppressor pathway and inhibiting the Tra...
Autores principales: | Landry, Natalie M., Rattan, Sunil G., Filomeno, Krista L., Meier, Thomas W., Meier, Simon C., Foran, Sarah J., Meier, Claire F., Koleini, Navid, Fandrich, Robert R., Kardami, Elissavet, Duhamel, Todd A., Dixon, Ian M. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043893/ https://www.ncbi.nlm.nih.gov/pubmed/33847835 http://dx.doi.org/10.1007/s00395-021-00865-9 |
Ejemplares similares
-
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
por: Koleini, Navid, et al.
Publicado: (2017) -
Ski drives an acute increase in MMP‐9 gene expression and release in primary cardiac myofibroblasts
por: Landry, Natalie, et al.
Publicado: (2018) -
Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway
por: Koleini, Navid, et al.
Publicado: (2018) -
Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathway
por: Koleini, Navid, et al.
Publicado: (2017) -
High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling
por: Santiago, Jon-Jon, et al.
Publicado: (2014)